60-Day Notice

64365

Federal Register / Vol. 83, No. 240 / Friday, December 14, 2018 / Notices
958, to the DEA Administrator, 28 CFR
0.100(b). Authority to exercise all
necessary functions with respect to the
promulgation and implementation of 21
CFR part 1301, incident to the
registration of manufacturers,
distributors, dispensers, importers, and
exporters of controlled substances (other
than final orders in connection with
suspension, denial, or revocation of
registration) has been delegated to the
Assistant Administrator of the DEA
Diversion Control Division (‘‘Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
Therefore, in accordance with 21
U.S.C. 958(i) and 21 CFR 1301.34(a),
this is notice that on June 11, 2018,
Arizona Department of Corrections,
1305 E Butte Avenue, ASPC-Florence,
Florence, Arizona 85132–9221, reapplied to be registered as an importer
of Pentobarbital (2270), a basic class of
the controlled substance listed in
schedule II.
The facility intends to import the
above-listed controlled substance for
legitimate use. This particular
controlled substance is not available for
the intended legitimate use within the
current domestic supply of the United
States.
Any bulk manufacturer who is
presently, or is applying to be,
registered with DEA to manufacture this
basic class of controlled substance may
file comments or objections to the
issuance of the proposed registration or
to the authorization of this importation,

and may, at the same time, file a written
request for a hearing. Any such
comments, objections, or hearing
requests should be addressed as
described above.
Dated: December 4, 2018.
John J. Martin,
Assistant Administrator.
[FR Doc. 2018–27131 Filed 12–13–18; 8:45 am]
BILLING CODE 4410–09–P

Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All requests for hearing
should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/OALJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DPW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Assistant
Administrator of the DEA Diversion
Control Division (‘‘Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.34(a), this is notice that on October
31, 2018, Usona Institute, 2800 Woods
Hollow Road, Madison, Wisconsin
53711 applied to be registered as an
importer of the following basic classes
of controlled substances:

SUPPLEMENTARY INFORMATION:

DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]

Importer of Controlled Substances
Application: Usona Institute
ACTION:

Notice of application.

Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before January 14, 2019. Such
persons may also file a written request
for a hearing on the application on or
before January 14, 2019.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for hearing must be
sent to: Drug Enforcement
DATES:

Controlled substance

Drug code

5-Methoxy-N-N-dimethyltryptamine .................................................................................................................................
Dimethyltryptamine ..........................................................................................................................................................

The institute plans to import the
listed controlled substances for
potential formulation development for
substances to be used in institutesponsored research.
Dated: December 4, 2018.
John J. Martin,
Assistant Administrator.
[FR Doc. 2018–27133 Filed 12–13–18; 8:45 am]
BILLING CODE 4410–09–P

DEPARTMENT OF JUSTICE
OMB Number 1117–0008]

Agency Information Collection
Activities; Proposed eCollection,
eComments Requested; Extension
Without Change of a Previously
Approved Collection; Application for
Procurement Quota for Controlled
Substance and for Ephedrine,
Pseudoephedrine, and
Phenylpropanolamine; DEA Form 250
Drug Enforcement
Administration, Department of Justice.
ACTION: 60-Day Notice.

amozie on DSK3GDR082PROD with NOTICES1

AGENCY:

The Department of Justice,
Drug Enforcement Administration
(DEA), will be submitting the following
information collection request to the
Office of Management and Budget for

SUMMARY:

VerDate Sep<11>2014

16:57 Dec 13, 2018

Jkt 247001

PO 00000

Frm 00055

Fmt 4703

Sfmt 4703

7431
7435

Schedule
I
I

review and approval in accordance with
the Paperwork Reduction Act of 1995.
DATES: Comments are encouraged and
will be accepted for 60 days until
February 12, 2019.
FOR FURTHER INFORMATION CONTACT: If
you have comments, especially on the
estimated public burden or associated
response time, suggestions, or need a
copy of the proposed information
collection instrument with instructions
or additional information, please
contact Kathy L. Federico, Diversion
Control Division, Drug Enforcement
Administration; Mailing Address: 8701
Morrissette Drive, Springfield, Virginia
22152; Telephone: (202) 598–6812.
SUPPLEMENTARY INFORMATION: Written
comments and suggestions from the
public and affected agencies concerning
the proposed collection of information
are encouraged. Your comments should

E:\FR\FM\14DEN1.SGM

14DEN1

64366

Federal Register / Vol. 83, No. 240 / Friday, December 14, 2018 / Notices

amozie on DSK3GDR082PROD with NOTICES1

address one or more of the following
four points:
—Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
—Evaluate the accuracy of the agency’s
estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
—Evaluate whether and if so how the
quality, utility, and clarity of the
information proposed to be collected
can be enhanced; and
—Minimize the burden of the collection
of information on those who are to
respond, including through the use of
appropriate automated, electronic,
mechanical, or other technological
collection techniques or other forms
of information technology, e.g.,
permitting electronic submission of
responses.
Overview of This Information
Collection
1. Type of Information Collection:
Extension of a currently approved
collection.
2. Title of the Form/Collection:
Application for Procurement Quota for
Controlled Substance and for
Ephedrine, Pseudoephedrine, and
Phenylpropanolamine.
3. The agency form number, if any,
and the applicable component of the
Department sponsoring the collection:
DEA Form 250. The applicable
component within the Department of
Justice is the Drug Enforcement
Administration, Diversion Control
Division.
4. Affected public who will be asked
or required to respond, as well as a brief
abstract:
Affected public (Primary): Business or
other for-profit.
Affected public (Other): None.
Abstract: Pursuant to 21 U.S.C. 826
and 21 CFR 1303.12(b) and 1315.32, any
person who desires to use, during the
next calendar year, any basic class of
controlled substances listed in
schedules I or II, or the List I chemicals
ephedrine, pseudoephedrine, or
phenylpropanolamine for purposes of
manufacturing must apply on DEA
Form 250 for a procurement quota for
such class or List I chemical.
5. An estimate of the total number of
respondents and the amount of time
estimated for an average respondent to
respond: The DEA estimates 344
respondents complete 3,066 DEA Form
250 applications annually, and that each
form requires 0.5 hours to complete.

VerDate Sep<11>2014

16:57 Dec 13, 2018

Jkt 247001

6. An estimate of the total public
burden (in hours) associated with the
proposed collection: The DEA estimates
this collection takes a total of 1,533
annual burden hours.
If additional information is required,
please contact: Melody Braswell,
Department Clearance Officer, United
States Department of Justice, Justice
Management Division, Policy and
Planning Staff, Two Constitution
Square, 145 N Street NE, Suite 3E.405B,
Washington, DC 20530.
Dated: December 10, 2018.
Melody Braswell,
Department Clearance Officer for PRA, U.S.
Department of Justice.
[FR Doc. 2018–27059 Filed 12–13–18; 8:45 am]
BILLING CODE 4410–09–P

DEPARTMENT OF JUSTICE

Overview of This Information
Collection:

[OMB Number 1117–0029]

Agency Information Collection
Activities; Proposed eCollection,
eComments Requested; Extension
Without Change of a Previously
Approved Collection; Annual
Reporting Requirement for
Manufacturers of Listed Chemicals
Drug Enforcement
Administration, Department of Justice.
ACTION: 60-Day Notice.
AGENCY:

The Department of Justice,
Drug Enforcement Administration
(DEA), will be submitting the following
information collection request to the
Office of Management and Budget for
review and approval in accordance with
the Paperwork Reduction Act of 1995.
DATES: Comments are encouraged and
will be accepted for 60 days until
February 12, 2019.
FOR FURTHER INFORMATION CONTACT: If
you have comments, especially on the
estimated public burden or associated
response time, suggestions, or need a
copy of the proposed information
collection instrument with instructions
or additional information, please
contact Kathy L. Federico, Diversion
Control Division, Drug Enforcement
Administration; Mailing Address: 8701
Morrissette Drive, Springfield, Virginia
22152; Telephone: (202) 598–6812.
SUPPLEMENTARY INFORMATION: Written
comments and suggestions from the
public and affected agencies concerning
the proposed collection of information
are encouraged. Your comments should
address one or more of the following
four points:
—Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
SUMMARY:

PO 00000

Frm 00056

Fmt 4703

Sfmt 4703

functions of the agency, including
whether the information will have
practical utility;
—Evaluate the accuracy of the agency’s
estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
—Evaluate whether and if so how the
quality, utility, and clarity of the
information proposed to be collected
can be enhanced; and
—Minimize the burden of the collection
of information on those who are to
respond, including through the use of
appropriate automated, electronic,
mechanical, or other technological
collection techniques or other forms
of information technology, e.g.,
permitting electronic submission of
responses.

1. Type of Information Collection:
Extension of a currently approved
collection.
2. Title of the Form/Collection:
Annual Reporting Requirement for
Manufacturers of Listed Chemicals.
3. The agency form number, if any,
and the applicable component of the
Department sponsoring the collection:
Form number: N/A. The applicable
component within the Department of
Justice is the Drug Enforcement
Administration, Diversion Control
Division.
4. Affected public who will be asked
or required to respond, as well as a brief
abstract:
Affected public (Primary): Business or
other for-profit.
Affected public (Other): None.
Abstract: Pursuant to 21 U.S.C.
830(b)(2) and 21 CFR 1310.05(d),
manufacturers of listed chemicals must
file annual reports of manufacturing,
inventory, and use data for the listed
chemicals they manufacture. These
reports allow the DEA to monitor the
volume and availability of domestically
manufactured listed chemicals, which
may be subject to diversion for the illicit
production of controlled substances.
5. An estimate of the total number of
respondents and the amount of time
estimated for an average respondent to
respond: Each respondent for this
information collection completes one
response per year. The DEA estimates
there are 50 respondents, and that each
response takes 0.25 hours to complete.
6. An estimate of the total public
burden (in hours) associated with the
proposed collection: The DEA estimates
this collection takes a total of 12.5
annual burden hours.

E:\FR\FM\14DEN1.SGM

14DEN1